Sort
64,565 grants matching “drug discovery”
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$552,186Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2021 · CA
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$552,186Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2019 · CA
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$552,186Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2020 · CA
High-throughput Identification of Non-hallucinogenic Psychoplastogens for Treating Addiction
$552,154David E Olson · University Of California At Davis · R01 · FY2022 · DA
Development of a Low Cost High Performance Animal PET
$552,153Wai-Hoi Wong · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · EB
Mid Southern Primary Care Networks Node
$552,141Li-Tzy T Wu · Duke University · UG1 · FY2019 · DA
Biochemical, Biophysical, and Structural Mechanisms of HIV-1 Budding and Release
$552,123James H Hurley · University Of California Berkeley · R37 · FY2025 · AI
Biglycan as a Therapeutic for Muscular Dystrophy
$552,091Lifecell Corporation · R44 · FY2003 · NS
Tau accumulation in the pedunculopontine tegmentum as an early node in Progressive Supranuclear Palsy pathogenesis
$552,090Stewart Donaldson Clark · State University Of New York At Buffalo · R56 · FY2020 · NS
Fully Automated Angiogenesis Drug Discovery Assay in Zebrafish
$552,075Anthony A Ferrante · Physical Sciences, Inc · R44 · FY2012 · HL
Precision Medicine Digital Twins for Alzheimerâs Target and Drug Discovery and Longevity
$552,045Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · R33 · FY2025 · AG
Chemical Synthesis of Chiral Bioactive Molecules
$551,982Sarah Elizabeth Reisman · California Institute Of Technology · R35 · FY2018 · GM
Chemical Synthesis of Chiral Bioactive Molecules
$551,982Sarah Elizabeth Reisman · California Institute Of Technology · R35 · FY2017 · GM
Chemical Synthesis of Chiral Bioactive Molecules
$551,982Sarah Elizabeth Reisman · California Institute Of Technology · R35 · FY2019 · GM
Chemical Synthesis of Chiral Bioactive Molecules
$551,982Sarah Elizabeth Reisman · California Institute Of Technology · R35 · FY2020 · GM
Pharmacology of HIV Viral DNA & Retroviral Integrases
$551,978Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Discovering Antimicrobial Drugs from Symbiotic Actinobacteria from Terrestrial
$551,928Cameron Robert Currie · University Of Wisconsin-Madison · U19 · FY2017 · AI
Therapeutic Inhibition of MIF in Rheumatoid Arthritis
$551,896Karen G. Anthony · L2 Diagnostics, Llc · R44 · FY2012 · AR
Inherited genetic risk factors common to COPD and lung cancer.
$551,872James C Willey · University Of Toledo Health Sci Campus · R01 · FY2011 · HL
Optimizing Enhanced Hammerhead Ribozymes for Retinal Nucleic Acid Therapeutics
$551,850John M Sullivan · State University Of New York At Buffalo · R01 · FY2025 · EY
Genetic Determinants of Tumor Growth and Drug Sensitivity in EGFR Mutant Lung Cancer
$551,847Katerina Abigail Politi · Yale University · R01 · FY2025 · CA
Depot formulation of a D-peptide HIV entry inhibitor
$551,835Alan L Mueller · Navigen, Inc. · R01 · FY2019 · AI
Cancer Research Training in Molecular Biology
$551,819University Of Virginia Charlottesville · T32 · FY2002 · CA
Mechanisms of Pain Associated with Trigeminal Nerve Injury
$551,793Michael S Gold · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · NS
Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
$551,629Jie Wu · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · CA